ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,766,311 | +73.1% | 1,133,615 | +96.1% | 0.10% | +72.7% |
| Q2 2023 | $17,769,350 | +61.4% | 578,053 | +89.2% | 0.06% | +41.0% |
| Q1 2023 | $11,007,454 | -13.4% | 305,508 | -5.0% | 0.04% | -15.2% |
| Q4 2022 | $12,707,972 | +4.4% | 321,558 | +6.1% | 0.05% | -19.3% |
| Q3 2022 | $12,178,000 | -20.9% | 303,093 | -17.2% | 0.06% | -12.3% |
| Q2 2022 | $15,395,000 | +124.4% | 366,203 | +107.9% | 0.06% | +170.8% |
| Q1 2022 | $6,861,000 | +321.4% | 176,115 | +331.1% | 0.02% | +380.0% |
| Q4 2021 | $1,628,000 | +54.0% | 40,856 | +68.6% | 0.01% | 0.0% |
| Q1 2021 | $1,057,000 | -32.2% | 24,232 | -34.6% | 0.01% | -16.7% |
| Q3 2020 | $1,559,000 | – | 37,062 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |